Dr. Mark Bradshaw, M.D

NPI: 1346355518
Total Payments
$5,627
2024 Payments
$425.06
Companies
35
Transactions
369
Medicare Patients
7,166
Medicare Billing
$354,449

Payment Breakdown by Category

Food & Beverage$5,606 (99.6%)
Education$20.67 (0.4%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $5,606 365 99.6%
Education $20.67 4 0.4%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $932.97 62 $0 (2024)
ABBVIE INC. $793.99 58 $0 (2024)
PFIZER INC. $773.81 74 $0 (2024)
GlaxoSmithKline, LLC. $465.79 28 $0 (2023)
Boehringer Ingelheim Pharmaceuticals, Inc. $340.97 11 $0 (2021)
Janssen Pharmaceuticals, Inc $328.49 23 $0 (2018)
Sunovion Pharmaceuticals Inc. $310.09 17 $0 (2022)
AstraZeneca Pharmaceuticals LP $286.23 17 $0 (2024)
Novartis Pharmaceuticals Corporation $161.49 5 $0 (2022)
Amgen Inc. $151.43 10 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $425.06 26 Almatica Pharma LLC ($81.84)
2023 $893.90 55 AbbVie Inc. ($275.10)
2022 $847.84 58 ABBVIE INC. ($293.21)
2021 $900.14 67 PFIZER INC. ($176.22)
2020 $149.06 9 PFIZER INC. ($56.29)
2019 $188.20 12 Novo Nordisk Inc ($148.92)
2018 $766.14 47 Novo Nordisk Inc ($175.98)
2017 $1,457 95 Janssen Pharmaceuticals, Inc ($298.86)

All Payment Transactions

369 individual payment records from CMS Open Payments — Page 1 of 15

Date Company Product Nature Form Amount Type
12/12/2024 Almatica Pharma LLC LOREEV XR (Drug) Food and Beverage In-kind items and services $13.15 General
Category: ANTI-ANXIETY
11/04/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $13.18 General
Category: Diabetes
09/10/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $14.80 General
Category: Diabetes
09/09/2024 CVRx, Inc. Barostim Neo System (Device) Food and Beverage Cash or cash equivalent $16.43 General
Category: Heart Failure and Hypertension
08/27/2024 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $14.74 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
08/08/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $14.37 General
Category: Respiratory
07/25/2024 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $16.08 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
07/10/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $22.40 General
Category: NEUROSCIENCE
07/09/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $16.09 General
Category: Diabetes
06/20/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $17.30 General
Category: Cardiovascular and Metabolism
06/13/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $17.97 General
Category: NEUROSCIENCE
05/29/2024 Almatica Pharma LLC LOREEV XR (Drug) Food and Beverage In-kind items and services $18.03 General
Category: ANTI-ANXIETY
05/23/2024 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $14.19 General
Category: Cardiovascular
04/16/2024 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $21.27 General
Category: NEUROSCIENCE
03/27/2024 Amgen Inc. Otezla (Drug) Food and Beverage In-kind items and services $18.49 General
Category: Inflammation
03/27/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $15.35 General
Category: Cardiology
03/14/2024 Almatica Pharma LLC LOREEV XR (Drug) Food and Beverage In-kind items and services $17.62 General
Category: ANTI-ANXIETY
03/13/2024 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $17.57 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
03/08/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $14.00 General
Category: Cardiovascular and Metabolism
02/26/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $13.97 General
Category: Cardiovascular and Metabolism
02/22/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $14.97 General
Category: Diabetes
02/15/2024 Almatica Pharma LLC LOREEV XR (Drug) Food and Beverage In-kind items and services $13.92 General
Category: ANTI-ANXIETY
02/05/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $17.33 General
Category: NEUROSCIENCE
01/24/2024 Almatica Pharma LLC LOREEV XR (Drug) Food and Beverage In-kind items and services $19.12 General
Category: ANTI-ANXIETY
01/17/2024 Boston Scientific Corporation WATCHMAN FLX (Device) Food and Beverage In-kind items and services $16.14 General
Category: WATCHMAN FLX_IC

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 15 944 1,430 $181,853 $80,427
2022 28 1,853 2,392 $186,224 $91,791
2021 28 2,373 3,564 $210,412 $107,279
2020 28 1,996 2,847 $169,372 $74,952
Total Patients
7,166
Total Services
10,233
Medicare Billing
$354,449
Procedure Codes
104

All Medicare Procedures & Services

104 procedure records from CMS Medicare Utilization — Page 1 of 5

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 312 639 $63,920 $23,299 36.5%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Facility 2023 159 159 $27,825 $18,560 66.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 219 331 $46,340 $17,959 38.8%
99496 Transitional care management services for problem of high complexity Facility 2023 33 38 $8,360 $5,321 63.6%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 32 56 $9,800 $4,799 49.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 22 22 $3,080 $1,883 61.1%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 13 15 $4,875 $1,784 36.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 23 23 $2,405 $1,342 55.8%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 21 26 $3,120 $1,336 42.8%
99495 Transitional care management services for problem of at least moderate complexity Facility 2023 11 11 $2,365 $1,130 47.8%
99238 Hospital discharge day management, 30 minutes or less Facility 2023 12 12 $1,440 $707.76 49.2%
17000 Destruction of precancer skin growth, 1 growth Facility 2023 14 15 $1,920 $562.01 29.3%
20610 Aspiration and/or injection of fluid from large joint Facility 2023 16 22 $2,090 $484.63 23.2%
99212 Established patient office or other outpatient visit, 10-19 minutes Facility 2023 19 21 $1,260 $415.36 33.0%
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and Facility 2023 11 12 $888.00 $411.07 46.3%
99203 New patient office or other outpatient visit, 30-44 minutes Facility 2023 13 13 $2,015 $386.77 19.2%
81001 Manual urinalysis test with examination using microscope, automated Office 2023 14 15 $150.00 $46.65 31.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 298 487 $50,340 $22,444 44.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 158 206 $31,577 $14,650 46.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 141 167 $16,700 $7,862 47.1%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Facility 2022 52 52 $9,100 $6,165 67.7%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 49 49 $8,965 $5,842 65.2%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 44 68 $10,998 $5,136 46.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 60 64 $8,960 $4,349 48.5%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 23 23 $7,103 $3,099 43.6%

About Dr. Mark Bradshaw, M.D

Dr. Mark Bradshaw, M.D is a Family Medicine healthcare provider based in Wynne, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346355518.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Bradshaw, M.D has received a total of $5,627 in payments from pharmaceutical and medical device companies, with $425.06 received in 2024. These payments were reported across 369 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($5,606).

As a Medicare-enrolled provider, Bradshaw has provided services to 7,166 Medicare beneficiaries, totaling 10,233 services with total Medicare billing of $354,449. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Wynne, AR
  • Active Since 08/20/2006
  • Last Updated 03/29/2012
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1346355518

Products in Payments

  • ELIQUIS (Drug) $519.94
  • UBRELVY (Drug) $479.27
  • Ozempic (Drug) $459.95
  • TRELEGY ELLIPTA (Drug) $327.87
  • JARDIANCE (Drug) $287.69
  • QULIPTA (Drug) $257.08
  • FARXIGA (Drug) $210.70
  • XARELTO (Drug) $189.93
  • Tresiba (Drug) $169.71
  • ENTRESTO (Drug) $161.49
  • GEMTESA (Drug) $158.89
  • CHANTIX (Drug) $158.48
  • Victoza (Drug) $142.01
  • INVOKANA (Drug) $138.56
  • AREXVY (Drug) $123.74
  • LOREEV XR (Drug) $121.83
  • Ranexa (Drug) $100.00
  • Utibron (Drug) $93.82
  • LYRICA (Drug) $88.16
  • TOUJEO (Drug) $85.14

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Wynne